The Worldwide Clinical Decision Support Systems Industry is Expected to Reach $8.2 Billion by 2027

DUBLIN, March 21, 2022 /PRNewswire/ -- The "Global Clinical Decision Support Systems Market By Component, By Product, By Delivery Mode, By Application, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027" report has been added to ResearchAndMarkets.com's offering.

The Global Clinical Decision Support Systems Market size is expected to reach $8.2 billion by 2027, rising at a market growth of 10.7% CAGR during the forecast period.

Clinical decision support systems (CDSS) are applications that are based on computers which collect and analyze data from electronic health records (EHRs) and offer cues and reminders to assist healthcare practitioners in following evidence-based clinical standards at the point of treatment. This Domain 3 strategy, when applied to CVD prevention, can help providers in a variety of ways, such as reminding them to screen for CVD risk factors, flagging cases of hypertension or hyperlipidemia, providing information on treatment protocols, prompting questions about medication adherence, and providing tailored recommendations for health behavior changes.

According to the World Ageing 2019 report, the world's population of people aged 65 and above was predicted to be 703 million in 2019. This group of people is prone to a variety of chronic diseases and requires regular health screenings and treatments to stay healthy. According to the current circumstances around the world, many people belonging to elderly and pregnant women segment, may require health examinations, but hospitals and clinics are unable to deliver these services owing to the global COVID-19 outbreak.

In recent years, a major increase in the number of hospitals and healthcare institutions that have adopted various forms and levels of clinical decision support systems has created a considerable opportunity for increased adoption in the near future. In industrialized regions, demand for decision assistance based on factual evidence and real-time knowledge has increased at a quicker adoption rate.

The number of agreements between CDSS providers and hospitals has increased significantly in recent years. Companies collaborate to develop and supply software that is up to date with the updated knowledge. The demand is expected to rise further as a result of government recognition and activities to stimulate the deployment of CDSS and EHR systems.

COVID-19 Impact Analysis

COVID-19 emerged as a very deadly infection that caused a significant number of deaths around the world. Additionally, the COVID-19 pandemic also devastated businesses across the world irrespective of their sizes. During the pandemic, the healthcare infrastructure of various companies failed due to the sudden outburst of the infection which resulted in an unexpected count of patients in urgent requirement of hospitalization. Resultantly, CDSS providers and groups have launched measures to aid in the fight against the pandemic.

CDSS has been shown to be an important weapon in the fight against COVID-19, demonstrating how healthcare teams can stay up to date on the newest COVID information and intelligence, hence improving the quality of treatment they give. Patients with a moderate to high chance of COVID-19 should have their COVID-19 test repeated, according to the Infectious Diseases Society of America.

Market Growth Factors:

The emergence of economies

Some of the growth catalysts for the market include the deployment of government policies boosting the adoption of HCIT solutions, rising government healthcare expenditure, and the availability of qualified IT experts in emerging countries around the world. Authorities in different countries are concentrating on revamping the healthcare management sector, which is currently confronting issues such as a statewide scarcity of doctors, underfunded rural health centers, overburdened metropolis hospitals, and confusing patient data systems.

Enhancement across clinical management

In various studies, it has been found that CDSS enhances adherence to clinical guidelines. Traditional clinical guidelines and treatment pathways have been demonstrated to be challenging to apply in practice due to low physician adherence. The expectation that practitioners will read, internalize, and apply new standards has not been shown to be true. The rules implicitly contained in recommendations, on the other hand, can be literally encoded in CDSS. CDSS can take many different forms, including standardized order sets for a certain case, alerts to a specific protocol for the patients involved, testing reminders, and so on.

Marketing Restraining Factor:

Technical difficulties and installation obstacles

In a variety of areas, clinical decision support systems encounter significant technical obstacles. Biological systems are extremely complex, and a therapeutic choice may rely on a vast amount of potentially relevant information. When recommending a patient's course of treatment, an electronic evidence-based medicine system might take into account the patient's symptoms, medical history, family history, and genetics, as well as historical and geographical trends in disease occurrence and published clinical data on medicinal effectiveness.

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Jun - 2021, Nov) Leading Players

Chapter 4. Global Clinical Decision Support Systems Market by Component
4.1 Global Services Market by Region
4.2 Global Hardware Market by Region
4.3 Global Software Market by Region

Chapter 5. Global Clinical Decision Support Systems Market by Product
5.1 Global Standalone CDSS Market by Region
5.2 Global Integrated CDSS with CPOE & E.H.R. Market by Region
5.3 Global Integrated E.H.R. with CDSS Market by Region
5.4 Global Other Product Market by Region

Chapter 6. Global Clinical Decision Support Systems Market by Delivery Mode
6.1 Global On-premise Systems Market by Region
6.2 Global Web-based Systems Market by Region
6.3 Global Cloud-based Systems Market by Region

Chapter 7. Global Clinical Decision Support Systems Market by Application
7.1 Global Drug Allergy Alerts Market by Region
7.2 Global Drug-drug Interactions Market by Region
7.3 Global Clinical Guidelines Market by Region
7.4 Global Drug Dosing Support Market by Region
7.5 Global Clinical Reminders Market by Region
7.6 Global Others Market by Region

Chapter 8. Global Clinical Decision Support Systems Market by Region

Chapter 9. Company Profiles
9.1 Siemens Healthineers AG (Siemens AG)
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments
9.1.5.1 Partnerships, Collaborations, and Agreements
9.2 Cerner Corporation (Oracle Corporation)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments
9.2.5.1 Partnerships, Collaborations, and Agreements
9.3 AllScripts Healthcare Solutions, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional & Segmental Analysis
9.3.4 Research & Development Expenses
9.4 General Electric (GE) Co. (GE Healthcare)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments
9.4.5.1 Partnerships, Collaborations, and Agreements
9.4.5.2 Product Launches and Product Expansions
9.5 NextGen Healthcare, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Research & Development Expense
9.5.4 Recent strategies and developments
9.5.4.1 Acquisitions and Mergers:
9.6 Athenahealth, Inc. (Veritas Capital)
9.6.1 Company overview
9.6.2 Recent strategies and developments
9.6.2.1 Partnerships, Collaborations, and Agreements
9.7 Epic Systems Corporation
9.7.1 Company Overview
9.7.2 Recent strategies and developments
9.7.2.1 Partnerships, Collaborations, and Agreements
9.8 eClinicalWorks LLC
9.8.1 Company Overview
9.9 Change Healthcare, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expenses
9.9.4 Recent strategies and developments
9.9.4.1 Partnerships, Collaborations, and Agreements
9.9.4.2 Product Launches and Product Expansions
9.9.4.3 Acquisition and Mergers:
9.10. Zynx Health, Inc. (Hearst Communications, Inc.)
9.10.1 Company Overview
9.10.2 Recent strategies and developments
9.10.2.1 Product Launches and Product Expansions

For more information about this report visit https://www.researchandmarkets.com/r/jn5dro

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets